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Zyxin is a cytoskeletal protein that controls cell movements by regulating actin ﬁlaments assembly, but it
can also modulate gene expression owing to its interactions with the proteins involved in signaling
cascades. Therefore, identiﬁcation of proteins that interact with Zyxin in embryonic cells is a promising
way to unravel mechanisms responsible for coupling of two major components of embryogenesis:
morphogenetic movements and cell differentiation. Now we show that in Xenopus laevis embryos Zyxin
can bind to and suppress activity of the primary effector of Sonic hedgehog (Shh) signaling cascade, the
transcription factor Gli1. By using loss- and gain-of-function approaches, we demonstrate that Zyxin is
essential for reduction of Shh signaling within the dorsal part of the neural tube of X. laevis embryo. Thus,
our ﬁnding discloses a novel function of Zyxin in ﬁne tuning of the central neural system patterning
which is based on the ventral-to-dorsal gradient of Shh signaling.
& 2013 Elsevier Inc. All rights reserved.Introduction
Zyxin is a LIM-domain protein present in low quantities that
binds to alpha-actinin and initiates nucleation and assembly of
actin ﬁlaments but is able to enter cell nuclei and interact with
proteins involved in the transcription machinery (Feng and
Longmore, 2005; Grunewald et al., 2009; Nix et al., 2001). Due
to such ambivalence, Zyxin is a good candidate for a mediator that
couples, during the development, cell morphogenetic movements
with gene expression. However, whereas the functions of Zyxin in
cultured animal cells have been studied intensively, its role in
embryogenesis remains elusive.
We showed recently that Zyxin inﬂuences early development
of Xenopus by suppressing activity of the homeodomain transcrip-
tion repressor Xanf1 in embryonic forebrain. (Martynova et al.,
2008). To look for any other protein regulators interacting with
Zyxin in embryogenesis, we used Zyxin as a bait for the yeast two-
hybrid screening of the cDNA expression library obtained from
Xenopus laevis embryos at the early neurula stage. Among the
proteins identiﬁed, the transcription factor Gli1, the primary
effector of Shh signaling cascade in Xenopus (Hui and Angers,
2011; Lee et al., 1997; Nguyen et al., 2005), especially attracted our
attention, because this interaction indicated possible involvementll rights reserved.
ky).of Zyxin in regulation of the Shh signaling. During gastrulation and
neurulation, Shh produced by the notochord and the neural plate
midline cells forms a bilateral transverse gradient across the
neural plate. This gradient plays a key role in early patterning of
the neural tube by stratifying the longitudinal expression zones of
speciﬁc genes within it (Ingham and McMahon, 2001; Patten and
Placzek, 2000; Ribes and Briscoe, 2009).
We next conﬁrmed the ability of Zyxin to speciﬁcally interact
with Gli1 and identiﬁed protein domains responsible for this
interaction. To test whether Zyxin affects Shh signaling in the
process of the central neural system (CNS) patterning, we used
loss-of-function approach and found that inhibition of translation of
the Zyxin mRNA resulted in an increase of Gli1 activity. Consistently,
gain-of-function approach revealed that Zyxin inhibits Shh/Gli1
signaling pathway in the neural tube and this inhibition depends
on the domain of Zyxin molecule responsible for the binding to Gli1.
In sum, these data demonstrate involvement of Zyxin into the ﬁne
tuning of Shh signaling during patterning of CNS.Materials and methods
DNA constructs, synthetic mRNA and Morpholino oligonucleotides
DNA cloning strategy and PCR primers are described in Table S1.
The synthetic mRNA and anti-sense RNA dig-labeled probes for
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T7 mМessage Мachine Kits (Ambion). The RNA templates were
puriﬁed by RNeasy Mini-columns Kit (QIAGEN). The antiZyxin
Morpholino oligonucleotide (antiZyxin Mo), complementary to both
Xenopus Zyxin pseudo-allelic mRNAs (5′-TGAAATGTTGATGGTGAAG-
GAGGAC), the control misantiZyxin Mo containing 7 mis-matches
with antiZyxin Mo (5′-TcAAtTGTTaATGGTtAAGcAccAC) and pre-
viously described Morpholinos to X. laevis Gli1 and Gli2 mRNAs
(Nguyen et al., 2005) were obtained from Gene Tools LLC.
Yeast two-hybrid screening
Yeast two-hybrid screenings were performed as described
previously (Martynova et al., 2008) by using the X. laevis embryo
stage 12 Matchmaker LexA cDNA Library constructed in pB42AD
cloning vector (Clontech Laboratories) (see Table S1 for cloning
strategy).
Luciferase assay
For luciferase reporter assay, embryos were injected as
described (Eroshkin et al., 2002) at 2–4 cell stage with a mixture
of the 83′Gli-BSLuc plasmid (Sasaki et al., 1997), reference
pCMV-β-GAL plasmid (50 pg/embryo of each plasmids), in vivo
tracer Rhodamine Lysine Dextran (Invitrogen, 10 kD, 2.5 μg/μl),
corresponding mRNAs and/or Mos. At stage 10, animal caps (AC)
were extirpated under green light, cultured till stage-19 equivalent
and three replicate samples, each of 10 explants, were homoge-
nized on ice, centrifuged at 13,400 rpm for 30 min at 4 1C to
remove yolk and processed for luciferase analysis according to
Promega protocol.
Protein interaction assays and EMSA
Lysates of embryos were prepared as described (Martynova
et al., 2008). 600 ml aliquots of the supernatant were mixed with
EZview Red ANTI-FLAG M2 Afﬁnity Gel (Sigma) and incubated
with rotation overnight at 4 1C. After washing 5 times with IPB
(Martynova et al., 2008), protein complexes were removed from
beads by 0.5 mg/ml 3xFLAG peptide (Sigma) in IPB. Fragments of
Zyxin and Gli1 proteins were produced in E. coli by using
constructs in pQE-80 plasmid (Qiagen) (see Table S1 for cloning
strategy). The recombinant proteins were isolated by QIAexpres-
sionist method (Qiagen). For IP, aliquots of recombinant proteins
(3–7 mg) in IPB were mixed with EZview Red ANTI-MYC M2
Afﬁnity Gel (Sigma) and incubated with rotation overnight at
4 1C. After washing 5 times with IPB, protein complexes were
eluted with 0.3 mg/ml 3xMYC peptide (Sigma). For in vitro pull-
down assay, lysates were prepared as described (Martynova et. al.,
2008). For each experiment, agarose beads carrying 20–30 mg of
GST-fusion protein were equilibrated with Pull-Down Buffer (PDB)
containing 25 mM Tris–HCl, pH 7.5, 175 mM NaCl, 1 mM EDTA,
1 mM EGTA, 5% glycerol, 0.5% NP-40 and protease inhibitors
cocktail (Sigma) and incubated with 300 ml aliquot of the embryo
or bacterial lysates overnight at 4 1C. After washing 5 times with
PDB and equilibrating with 50 mM Tris–HCl, pH 8.0, protein
complexes were eluted from the matrix with 10 mM reduced
glutathione in 50 mM Tris–HCl, pH 8.0. Flag-, Myc- and His-tagged
proteins were analyzed by Western blotting with anti-Flag M2,
anti-Myc (clone 9E10) and anti-His monoclonal antibodies con-
jugated to alkaline phosphatase (Sigma, dilution 1:1000). Rabbit
antiZyxin antibody (Martynova et.al., 2008) and secondary anti-
Rabbit antibody conjugated to Alkaline Phosphatase (Sigma) were
used for Zyxin detection. EMSA was performed as described in
(Martynova et al., 2004).Cell culture, transgenic embryos, immunohistochemistry, in situ
hybridization and statistical analysis
X. laevis ﬁbroblasts (XEF) were cultured, transfected and
stained with anti-Myc antibody (Sigma) as described in
(Martynova et al., 2008). Immunolabeling and EGFP ﬂuorescence
was viewed by using a Zeiss Axiophot 35 microscope. Transgenic
embryos of the 2nd-generation expressing Zyxin-EGFP under CMV
promoter were obtained from transgenic frogs previously gener-
ated and maintained in our lab (G.V. Ermakova, unpublished).
Whole-mount in situ hybridization was performed as described in
(Harland, 1991) with the dig-labeled probes. After hybridization
was complete, embryos were embedded in 3% agarose and
dissected into serial 30 μm sections using a HM 650V Vibrating
Blade Microtome. Alternatively, embryos were embedded in 3%
agarose ﬁrst and then dissected into serial 30 μm sections, which
were subjected to hybridization procedure; each section being
processed individually according to the protocol described by
Harland (1991).
To determine nucleus/cytoplasm ratio for ﬂuorescent signals in
cells transfected with the plasmids expressing Myc-tagged Gli1
and either Zyxin-EGFP or EGFP, the integrated density was
measured in arbitrary units within the round 1 mm window using
ImageJ image processing program (http://rsb.info.nih.gov/ij/index.
html). Statistical signiﬁcance of the numerical data shown in
Figs. 2, 4, 6–8 was estimated by using the independent two-
sample Student's t-test for unequal sample sizes.Results
Zyxin interacts with the intracellular effector of the Shh signaling
cascade, the zinc-ﬁnger transcription factor Gli1
To identify proteins that interact with Zyxin, we performed
yeast two-hybrid screening of the cDNA expression library
obtained from X. laevis embryos at gastrula–neurula stage. Since
the N-terminal part of Zyxin, including proline-rich clusters and
NES, by itself induces strong activation of the reporter genes (Li
and Trueb, 2001), only C-terminal Zyxin portion containing three
LIM-domains (Zyxin-LIM1-3) was used as a bait in this screen
(Fig. 1A).
Among 39 truly positive cDNA clones, encoding in total 12
various proteins, the zinc-ﬁnger transcription factor Gli1 was
selected for further analysis since it was known as the primary
effector of signaling pathway activated by Sonic hedgehog secreted
factor (Shh) during early patterning of the CNS in Xenopus (Lee
et al., 1997). The isolated cDNA encoded the fragment of Gli1
(Y-Gli1 in Fig. 1A) containing zinc-ﬁngers (220–1361 aa) respon-
sible for interaction of Gli1 with both DNA and protein partners
(Koyabu et al., 2001; Nguyen et al., 2005; Pavletich and Pabo,
1993). It was also important that Gli1 is expressed during neurula-
tion most abundantly in the dorsal tissues of Xenopus embryo,
including neural plate, i.e. just in the same region of embryo, in
which enhanced expression of Zyxin is observed (Lee et al., 1997;
Martynova et al., 2008).
Protein domains responsible for Zyxin binding to Gli1
We used immunoprecipitation (IP) to verify the speciﬁcity of
Zyxin–Gli1 interaction. For IP experiments, 2-cells embryos were
co-injected with two synthetic mRNAs, one of them encoded
FLAG-tagged LIM domains-containing C-terminal (455–664 а.a.)
fragment of Zyxin (FLAG-Zyx1-3LIM) and the other—Myc-tagged
Gli1, or Gli2, or Gli3, and formation of complexes between Zyxin
and Gli-variants was analyzed using anti-Myc antibody. As a result,
Fig. 1. Gli1 and Zyxin bind to each other directly and speciﬁcally. A. Principal scheme of Zyxin and Gli1 proteins and their fragments, whose interaction was revealed in yeast
two-hybrid screening. Region of Zyxin that causes autonomous reporter activity in yeast two-hybrid system (according to (Li and Trueb, 2001), and our own data) is
underlined by dotted line. Connecting arrows indicate the interacting protein domains. B. Comparison of Myc-tagged Gli1, Gli2 and Gli3 in IP assay with FLAG-ZyxinLIM1-3
from extracts of Xenopus embryos injected with the corresponding mRNAs. C. IP assay for Myc-Gli1 binding to the full-length Zyxin from extracts of Xenopus embryos
injected with the corresponding mRNAs. D. Two-hybrid analysis of the ability of Gli1 deletion mutants to bind ZyxinLIM1-3. Gli1 fragments, which can or cannot cause
activation of two reporter genes (LEU2 and LacZ) upon expression in yeast cells co-expressing ZyxinLIM1-3, are indicated by “+” or “−” respectively. E. Principal scheme of Gli1
zinc-ﬁngers 1-2- and 3-5- containing fragments used for IP assay with FLAG-ZyxinLIM1-3. F. IP assay for Myc-N-Gli1ZF1-2 and Myc-N-Gli1ZF3-5 (see principal scheme of
these protein fragments on D) binding to FLAG-ZyxinLIM1-3 in extracts of Xenopus embryos injected with the corresponding mRNAs. G. IP assay for 6His-Myc-Gli1ZF1-2 and
6His-Myc-Gli1ZF3-5 binding to 6His-ZyxinLIM1-3 (all proteins were produced in E. coli). H. In vitro pull-down assay for Myc-N-Gli1 and GST-fusions of individual LIM
domains of Zyxin. I. In vitro pull-down assay for 6His-Myc-Gli1ZF1-2 and GST-fusions of individual LIM domains of Zyxin.
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Fig. 2. Gli1 co-localizes with Zyxin in Xenopus laevis ﬁbroblasts. A–C. Cells expressing Myc-Gli1 (A), Zyxin-EGFP (B) or EGFP alone. Here and below, Myc-Gli1 was revealed by
Texas Red labeled anti-Myc antibody; n—nucleus; scale bar: 5 μm. D. A cell co-transfected with plasmids encoding the full-length Myc-Gli1and Zyxin-EGFP. White arrows
indicate true yellow color, which conﬁrm tight co-localization of two proteins. E. No co-localization (no true yellow color) of mutant Gli1, lacking zinc ﬁngers, and Zyxin is
seen in the cell co-transfected with pMyc-mutGli1and pZyxin-EGFP. F. Nuclear to cytoplasmic ﬂuorescence density ratio (DFR) in cells transformed with Myc-Gli1, Myc-
mutGli1and EGFP-Zyxin alone or together. DFR was calculated for 200 cells of each type in two independent experiments.
N.Y. Martynova et al. / Developmental Biology 380 (2013) 37–4840Zyxin was found to co-precipitate with Gli1, but not with Gli2
or Gli3 (Fig. 1B). The same result was obtained when co-
immunoprecipitation of full-length Zyxin and Gli1 was probed
using anti-Zyxin antibodies (Martynova et al., 2008) (Fig. 1C).
To determine a Gli1 region responsible for its binding to Zyxin,
we used, besides IP, the yeast LexA two-hybrid assay. cDNAs
encoding for several partially overlapping fragments of Gli1 were
sub-cloned into the bait vector pMW103, whereas the cDNA
encoding for the LIM-domains portion of Zyxin (373–664 a.a.)was inserted into the prey vector pB42AD (Fig. 1D). Zyxin–Gli1
interaction was analyzed qualitatively by growth on selective agar
plates and quantitatively by the β-galactosidase activity using
liquid culture colorimetric assay (according to Promega protocol).
As a result, strong signals were detected only with those yeast
clones that expressed cDNA fragments encoding the zing-ﬁnger
region of Gli1 (Fig. 1D).
The same result was obtained by using IP from lysates of
Xenopus embryos injected with mRNAs encoding the LIM-domain
Fig. 3. Shh, Gli1, Ptc2 and Zyxin expression in CNS of the Xenopus laevis embryo A–H. In situ hybridization with probes to Shh, Gli1, Ptc2 and Zyxin on successive sections of
two embryos, at stage 15 (A, C, E and G) and stage 27 (B, D, F and H). I and I′. The midneurula (stage 15) transgenic embryo expressing Zyxin-EGFP under the control of CMV
promoter. Zyxin-EGFP signal is concentrated (arrowheads) along apical membranes of the ﬂour plate cells. Dorsal view, anterior to the top. J and K. At the mid (stage 14) and
late (stage 18) neurula stage transgenic embryos, Zyxin-EGFP signal is concentrated (arrowheads) along membranes of the ﬂoor plate cells. Fp—ﬂoor plae, lnp—lateral neural
plate, ml and vl—mantle and ventricle layers of the neural tube respectively, hy—hypochord, np—neural plate, not—notochord, s—somite. Scale bar everywhere is 40 μm.
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the zinc-ﬁngers of Gli1, the 1st and 2nd domains, which does not
form tight contact with DNA (Pavletich and Pabo, 1993), proved to
be responsible for binding to Zyxin (Fig. 1E and F). This result was
further conﬁrmed by the direct in vitro interaction of the indicated
fragments of Zyxin and Gli1 puriﬁed from E. coli (Fig. 1G).
To identify the LIM domain of Zyxin required for its interaction
with Gli1, individual LIM domains were obtained as GST-fusions
and used as baits for pull-down of Myc-tagged N-terminal frag-
ment of Gli1 translated in Xenopus embryos. As a result, the second
LIM domain of Zyxin was identiﬁed as a site for Gli1 binding
(Fig. 1H). Direct interaction in vitro of translated E. coli Gli1
fragment containing 1 and 2 zinc-ﬁngers and second LIM domain
of Zyxin conﬁrmed this data (Fig. 1I). In accordance with these
observations, Zyxin lacking second LIM-domain (FLAG-Zyx-delta2)
demonstrated signiﬁcant though not full decrease in the Gli1
binding (Fig. S1C). Thus, Zyxin–Gli1 interaction depends on the
ﬁrst two zinc-ﬁngers of Gli1 and second LIM-domain of Zyxin.
Zyxin is co-localized with Gli1 in cultured Xenopus cells
Gli1 and Zyxin are known to be located primarily in different
cell compartments: in the nucleus and cytoplasm, respectively
(Fig. 2A and B). However, when Zyxin-EGFP and Myc-Gli1 were
co-expressed in cultured X. laevis ﬁbroblasts, the apparent
co-localization of these proteins along stress ﬁbers, in the focal
contacts, near the cell membrane and in the nucleus was observed
(yellow color indicated by arrows in Fig. 2D, merged). No such co-
localization was seen when Gli1 was substituted with a mutant
lacking the zinc-ﬁngers (absence of any site with true yellow color
on the merged image in Fig. 2E). Obviously, these results areconsistent with the IP data, which have demonstrated interaction
of Gli1 with Zyxin.
If Gli1 and Zyxin interact with each other, at the same time
keeping attraction to nucleus and cytoplasm, they may demon-
strate different intracellular distribution, depending on whether
they are expressed together or separately. To test whether this is
the case, we have compared nuclear to cytoplasmic ratio of the
ﬂuorescent signal for Myc-Gli1 or EGFP-Zyxin in cells transfected
either by each or both of these plasmids (Fig. 2F). As a result, we
observed statistically signiﬁcant changes of Myc-Gli1 ﬂuorescence
in favor of cytoplasm in cells expressing both proteins, in compar-
ison to those co-expressing Myc-Gli1 with EGFP as a control
(Fig. 2F, see bars a and b, e and f). On the contrary, ﬂuorescence
of EGFP-Zyxin changed in favor of nucleus in the double-
transfected cells (Fig. 2F, see bars e and f). These effects depended
on the zinc-ﬁnger domain of Gli1, because no redistribution of
ﬂuorescence was observed when the wild-type Gli1 was replaced
with its mutant lacking the zinc-ﬁngers (Fig. 2F, see bars c and d, e
and g). Obviously, these results conﬁrm the ability of Gli1 to
interact with Zyxin in living cells.
Localization of Zyxin mRNA and protein in the Xenopus embryo
during neurulation
To examine in more details how expression of Zyxin is disposed
to those of Gli1 and Shh directly in embryos, we performed in situ
hybridization with corresponding probes on successive vibratome
sections of individual midneurula (stage 15) and tailbud (stage 27)
embryos. In addition, we analyzed expression patterns of the gene
of Shh receptor Ptc2, which is a direct target for Gli1 (Takabatake
et al., 2000).
Fig. 4. Down-regulation of the endogenous Zyxin elicits Gli1-dependent activation
of Gli-Luc reporter. 8-cell embryos were injected in both dorsal blastomeres with
30 pg/embryo of 83′Gli-BS Luc and pCMV-βGal mixed either with antiZyxin
(0.1 mM), antimisZyxin (0.1 mM), Gli1 (0.5 mM), Gli2 (0.5 mM) Mo and Zyxin
mRNA as indicated. The reporter signal was measured at the end of gastrulation in
groups of 10 embryos of each type. Results of three independent experiments were
combined. Mean values of the luciferase signal are shown; bars indicate standard
deviation. For each type of experiments, value of the reporter signal was normal-
ized relative to the activity of β-Gal, followed by setting the value of control
experiment to 1.0.
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McMahon, 2001; Ribes and Briscoe, 2009), Shh expression was
observed in the notochord, median part of the neural plate and
tube and in the hypochord (Fig. 3A and B), whereas transcripts of
Gli1 and Ptc2, were revealed in cells adjacent to those expressing
Shh, including cells of internal parts of somites, the neural plate
and tube (Fig. 3C and D, E and F).
Although Zyxin gene was expressed ubiquitously, its transcripts
were more abundant in the dorsal tissues of embryos, including
the notochord, neural plate and tube (Fig. 3G and H). Somewhat
lower expression was observed in epidermis, and the lowest level
was seen in somites and endoderm. Importantly, whereas in the
neural plate maximums of Gli1, Ptc2 and Zyxin expression were
overlapped (Fig. 3C, E and G), in the neural tube Zyxin expression
pattern was partially complementary to those of Gli1 and Ptc2
(Fig. 3D, F and H). Thus, Zyxin transcripts were more abundant in
cells of the mantle layer of the neural tube, while lower expression
level was seen in cells of the ventricular layer. By contrast, Gli1 and
Ptc2 demonstrated reverse distribution of expression: with the
lowest level in the mantle layer and the highest level in the
ventricular layer. This observation suggests probable inhibitory
inﬂuence of Zyxin upon Shh signaling.
By using embryos of transgenic line ubiquitously expressing
Zyxin-EGFP fusion under the control of CMV promoter, we also
examined intracellular localization of Zyxin protein during neur-
ulation. We used this transgenic approach instead of revealing the
endogenous Zyxin by immunohistochemistry because the avail-
able antibodies provided unspeciﬁc signal on histological sections.
As a result, we revealed an increased attraction of Zyxin to
membranes of the ﬂoor plate cells (Fig. 3I–K). At the same time,
no such concentration of Zyxin was observed in the lateral zones
of the neural plate and in the mature ﬂoor plate of the closed
neural tube (Fig. 3I–K and Fig. S2). These data allow us to suggest
enhanced association of Zyxin with cytoskeleton in zones of the
intercellular contacts and near the apical membranes of the ﬂoor
plate cells.
Inhibition of the Zyxin mRNA translation by antisense Morpholino
stimulates Gli1 activity
To understand whether Zyxin is indeed critical for Gli1 activity
in normal development, we arranged loss-of-function experiments
by injecting embryos with antisense Morpholino oligonucleotide
(Mo) preventing translation of Zyxin mRNA (Martynova et al.,
2008). Previously, we observed disruption of intercellular contacts
in embryos injected with this Mo taken in commonly recom-
mended concentrations (0.5–1.0 mM) (Martynova et al., 2008);
therefore now, to avoid such an effect, the concentration of Mo
was reduced to 0.1 mM. As a result, the developing embryos
looked normal, at least up to the mid-neurula stage (stage
14–15), while overall amount of endogenous Zyxin diminished
and we were able to study the effect of Zyxin depletion on Gli1
activity during this short period (Fig. S3). It should be, however,
noted that the ectoderm of the Mo-treated embryos still became
disrupted by the end of neurulation, which resulted in developing
of abnormal embryos with CNS deprived of labeled cells in the CNS
(Movie S1 and Fig. S4D).
Supplementary material related to this article can be found
online at http://dx.doi.org/10.1016/j.ydbio.2013.05.005.
To estimate Gli activity, we used, as the most speciﬁc read-out,
the luciferase signal generated by the Gli-responsive reporter,
83′Gli-BS Luc (Sasaki et al., 1997). In these experiments, 16-cell
embryos were injected in two dorsal medial blastomeres (pre-
sumptive neural plate) with the mixture of antiZyxin Mo, 83′Gli-
BS Luc, pCMV-β-Gal (as a reference reporter) and RLD (as in vivo
tracer). At the early neurula stage, embryos demonstrating RLDsignal primarily in the neural plate were carefully selected and
analyzed for luciferase activity. A moderate (20% in average) but
stable (3 independent experiments, 10 embryos in each) increase
of the luciferase signal was observed in these embryos in compar-
ison with those injected by the mixture of the same reporter and
control misantiZyxin Mo (Fig. 4, compare bars a and b). This effect
was speciﬁc because co-injection of antiZyxin Mo with Zyxin
mRNA lacking the MO target site eliminated the increase of the
reporter expression (Fig. 4, compare b ars b and c).
As both Gli1 and Gli2, which operate as transcriptional activa-
tors, could potentially elicit such an increase of the reporter
expression, we then tested the reporter activity in conditions of
down-regulated Gli1 or Gli2. The reporter signal was signiﬁcantly
reduced when either Gli1 or Gli2 was down-regulated with the
corresponding antisense Mo, however, regular increase of the
reporter signal was observed only when antiZyxin Mo was co-
injected with antiGli2 but not with antiGli1 Mo (Fig. 4, compare
bars e and f, h and i). This result indicates that this was the
endogenous Gli1 whose activity gave rise to increase of the
reporter signal in embryos injected with antiZyxin Mo.
Down-regulation of the endogenous Zyxin leads to suppression of
genes whose expression is inhibited by high level of Shh signaling
As Gli1 plays a role of the primary effector of Shh signaling in
the X. laevis neural plate (Hui and Angers, 2011; Lee et al., 1997;
Nguyen et al., 2005), the obtained results predict inhibitory
inﬂuence of Zyxin upon this signaling. Therefore, we decided to
test the effect of Zyxin depletion on expression of several Shh
genetic targets. During neurulation, produced by the notochord
and ﬂoor plate cells Shh spreads laterally, forming a bilateral
concentration gradient, which establishes a speciﬁc spatial pattern
of Shh-responsive genes expression and cell differentiation along
the dorsal–ventral axis of the neural tube (Chamberlain et al.,
2008; Chiang et al., 1996; Ericson et al., 1995). The prevailing
model suggests that Class I of the Shh-responsive genes are
transcriptionally repressed, whereas Class II genes are transcrip-
tionally activated by high concentration of Shh near its natural
sources, i.e. the ﬂoor plate and notochord (Briscoe et al., 2000).
Unfortunately, due to the problem of neuroepithelium disin-
tegration by the end of neurulation in embryos injected with
Fig. 5. Expression of Shh genetic targets in the neural plate of embryos injected by AntiZyxin Mo. A–F. Almost complete inhibition of Pax6, Dbx1 and Olig4 expression
(normally inhibited by Shh signaling) in areas populated by cells containing antiZyxin Mo (see A″–F″ for localization of FLD tracer). Control embryos were injected with
misantiZyxin Mo. All embryos are shown from dorsal side, anterior to the top. Arrows indicate sites of the expression inhibition. Transverse sections of embryos at the level
indicated by dashed line on A–F are shown on A′–F′. G–L. A weak expansion of the Foxa2, Gli1 and Ptc2 expression (normally activated by high Shh signaling) in areas
populated by cells containing antiZyxin Mo (see G″–L″ for localization of FLD tracer). Yellow stripes indicate borders of expression domains. Transverse sections of embryos at
the level indicated by dashed line on G–L are shown on G′–L′.
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markers, which start to be expressed in the neural plate no later
than at the midneurula stage. For example, we were unable to use
such an important Class I marker as Nkx2.2, whose expression
begins in the cells of Xenopus lateral ﬂoor plate at the end of
neurulation (Saha et al., 1993). Accordingly, we chose Pax6/Dbx1/
Olig4 and Foxa2/Gli1/Ptc2 as suitable representatives of Shh-
repressed and Shh-activated genes respectively, whose expression
is reliably detected at the midneurula stage.
As a result, a signiﬁcant reduction of expression of all three
selected Class I genes was observed in cells containing antiZyxin
Mo: Dbx1 (31 of 34 embryos), Pax6 (35 of 36 embryos) and Olig4
(22 of 24 embryos) (Fig. 5B, D and F, arrows). No such abnormal-
ities were detected when misantiZyxin Mo was injected (Fig. 5A, C
and E). Importantly, co-injection of antiZyxin Mo with Zyxin
mRNA lacking the Mo target site resulted in a partial rescue of
expression and anatomical abnormalities (Fig. S4A–E) induced by
antiZyxin Mo alone.
By contrast, neither massive enhancement nor inhibition of
expression was detected for Foxa2, Gli1 and Ptc2, which arenormally expressed in the median part of the neural plate being
activated by high level of Shh signaling. However, in several
embryos (4 of 42 in the case of Foxa2, 5 of 39 in the case of Gli1
and 5 of 25 in the case of Ptc2) a weak expansion of the
longitudinal expression bands of these genes was still observed
(compare gaps between yellow lines on the photos of the mis-
antiZyxin Mo- and the antiZixin Mo-injected embryos at Fig. 5(G
and H for Foxa2, I and J for Gli1 and K and L for Ptc2)). These results
indicate that ventrally expressed Shh-activated genes are less
sensitive to the depletion of Zyxin than dorsally expressed Shh-
activated markers.
Overexpression of Zyxin inhibits Shh signaling in the developing CNS
The Shh-dependent patterning of the neural plate is a very
dynamic process, so the observed abnormalities of the marker
genes expression at the midneurula stage might be of only
transient character. To clarify whether Zyxin mis-expression may
also result in long-term consequences, we investigated effects of
Zyxin overexpression on expression patterns of four Shh-regulated
Fig. 6. Inﬂuence of Zyxin on Shh/Gli1-responsive genes in embryos with overexpressed Shh. 8-cells embryos were injected into the right dorsal blastomere with the
following amount of mRNAs indicated in the top line: Zyxin—150 pg/embryo; Shh—15 pg/embryo; Zyxin-Δ2LIM—150 pg/embryo, along with the living tracer, FLD. After
in situ hybridization of embryos at stage 25 with probes to Pax6 (A–D), Dbx1 (F–I), Nkx2.2 (K–N) and Foxa2 (P–S), sagittal projections of expression domains of each gene were
measured on the left (control) and right (injected) sides of the neural tube and percentage change of expression on the injected side (δ) was calculated (see diagrams in E and
O). Mean value and standard deviation of the expression domain changes for all embryos injected by the same set of mRNAs are shown on E, J, O and T by columnar
diagrams. Red bars on photos indicate borders of the expression domains on the injected and non-injected sides of embryos. Dotted line indicate border of the neural tube.
Red dotted lines on schematic representation of neural tube section on E indicates normal positions of the ventral borders of the expression domains of Pax6, n—number of
embryos analyzed in each case.
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stage. In this case, we took advantage of the fact that Zyxin
overexpression, in contrast to Mo treatment, does not cause
disintegration of embryos (Martynova et al., 2008).
When Zyxin mRNA was injected unilaterally, into one of two
dorsal blastomeres of the 8-cells embryos, comparatively weak but
statistically signiﬁcant expansion of the expression zones of Dbx1
and Pax6 (Class I genes), accompanied by a reduction of the
expression zones of Foxa2 and Nkx2.2 (Class II genes), was
observed on the injected sides of the neural tubes (Fig. 6A and E,
F and J, K and O, P and T; all embryos were sectioned transversely
at the middle of the hindbrain).
By contrast, injection of ShhmRNA produced an opposite effect,
i.e. reduction of the expression zones of Pax6 and Dbx1 andexpansion of the expression zones of Nkx2.2 and Foxa2 (Fig. 6B
and E, G and J, L and O, Q and T). Importantly, co-expression of Shh
and Zyxin partially rescued patterns of the Shh-responsive genes
disturbed by high Zyxin concentration; the result is consistent
with the hypothesis of the inhibitory inﬂuence of Zyxin upon Gli1
functioning (Fig. 6C and E, H and J, M and O, R and T).
This hypothesis is also in agreement with the results of
experiments, in which we observed inability of Zyxin mutant
deprived of the 2nd LIM domain and thus unable to bind Gli1, to
eliminate effects of the co-expressed Shh on the expression of Shh
genetic targets (Fig. 6D and E, I and J, N and O, S and T).
The same gain-of-function experiments were performed in
order to check whether Zyxin suppressed Shh signaling through
interaction with Gli1. To make this analysis more stringent,
Fig. 7. Inﬂuence of Zyxin on Gli1/Shh-responsive genes in embryos with overexpressed Gli1. Embryos were injected in the same way as that in Fig. 6, except that 10 pg/
embryo of Gli1 mRNA was injected instead of Shh mRNA. At stage 27, embryos were cut into successive transverse vibratome sections in the hindbrain region and four
sections of each embryo were hybridized individually with probes to Pax6 (A–C), Dbx1 (E–G), Nkx2.2 (I–K) and Foxa2 (M–O). For abbreviations, see Fig. 6.
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analyzed on serial sections of individual embryos. Practically, each
of four successive transverse sections of an embryo (Fig. 7,
columns), injected either with Gli1 mRNA alone or co-injected
with Gli1 mRNA and mRNA of wild-type Zyxin or Zyxin mutant
deprived of the 2nd LIM domain, was hybridized individually with
the probe to one of four genetic targets. In contrast to the
hindbrain level sections shown in Fig. 6, serial sections were
prepared in this series from the trunk region, located just posterior
to the hindbrain.
As a result, we found that whereas Gli1 induced a synchronized
enhancement/inhibition of expression of Pax6/Dbx1 and Nkx2.2/
Foxa2, respectively (Fig. 7A and D, E and H, I and L, M and P), this
effect of Gli1 was clearly suppressed by high concentration of
Zyxin, but not of Zyxin mutant (Fig. 7B and D,F and H, J and L, N
and P; C and D, G and H, K and L, O and P). Thus, these data also
conﬁrm inhibitory inﬂuence of Zyxin upon Shh/Gli1 signaling
pathway.Interaction with Zyxin prevents Gli1 binding to the promoters
of target genes
The obtained data allow to suggest that Zyxin interferes with
Shh signaling through binding to Gli1 thus inhibiting its function.
To verify this suggestion, Gli-responsive luciferase reporter, 83′
Gli-BS Luc was injected into 2–4 cells Xenopus embryos together
with (i) Gli1 mRNA alone, (ii) mRNAs of Gli1 and wild type Zyxin,
and (iii) mRNAs of Gli1 and mutant Zyxin, in which NES (Nuclear
Export Signal) was substituted by nuclear localization signal (NLS).
As a result, a signiﬁcant decrease of the luminescent signal was
observed in all cases when Zyxin was present; the effect being
more pronounced for Zyxin carrying NLS (Fig. 8A).
Although this result is consistent with the supposed inhibitory
inﬂuence of Zyxin upon Gli1 functioning, it does not disclose
mechanism of such inhibition. Indeed, upon binding to Gli1, Zyxin
might either prevent its interaction with the promoter or suppress
Gli1 functioning directly on the promoter. To choose between
Fig. 8. Zyxin interferes with Gli1 binding to its target promoter. A. Luciferase reporter assay of Zyxin effects upon Gli1, Gli2 and Gli3 activity. 83′Gli-BSLuc reporter (30 pg/
embryo) was mixed with the reference pCMV-β-GAL plasmid (30 pg/embryo), indicated mRNAs (Gli1-3–70 pg/embryo; Zyxin, NLS-Zyxin, EnR-Zyxin, VP16-Zyxin—150 pg/
embryo each); and injected into embryos at 2–4 blastomeres stage. All experiments were done in triplicates. See Fig. 1 and Martynova et al. (2008) for principal protein
structures. B. EMSA demonstrating reduced binding of Gli1 to its DNA target site in the presence of Zyxin.
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Gli1 binding to its DNA target by the Electrophoretic Mobility Shift
Assay (EMSA). For this analysis, extracts of embryos pre-injected
with Gli1 mRNA alone or together with Zyxin mRNA, were
incubated with P32-labeled double-stranded DNA fragment con-
taining the canonical Gli-binding site (Sasaki et al., 1997) and Gli1
binding to the labeled DNA was detected by gel-shift. A clear shift
of the labeled fragment was observed when exogenous Zyxin was
omitted from the assay, whereas the presence of ten times excess
of Zyxin in the embryo extract signiﬁcantly decreased the shifted
band intensity (Fig. 8B). Thus, Zyxin prevents Gli1 binding to DNA.
This conclusion was supported by experiments, in which
expression of the same Luc reporter was activated by Gli1 in the
presence of the LIM-domain-containing portion of Zyxin supple-
mented with NLS and fused with either the repressor domain of
Drosophila Engrailed (EnR, ultimate transcription repressor) or
activator domain of Herpes virus VP16 (VP16, ultimate transcrip-
tion activator). If Zyxin interacts with Gli1 when it is bound to the
promoter, one might expect to observe an increase of the reporter
expression activated by Gli1 in the case when the latter was co-
expressed with VP16-NLS-Zyxin fusion, and vice versa, inhibition
of the reporter expression in the case of Gli1 co-expression with
EnR-NLS-Zyxin fusion. However, in both cases strong inhibition of
the reporter expression was observed (Fig. 8A). Obviously, the
results of these experiments also indicate that Zyxin inhibits the
transcription function of Gli1 by preventing its interaction with
the promoters of target genes.Importantly, no effects of Zyxin co-expression were revealed in
the case of Gli2 and Gli3 (Fig. 8A), the result ﬁtting well with
inability of Zyxin to interact with these proteins, as well as with
inability of endogenous Gli2 to activate Gli-Luc reporter in condi-
tions of down-regulated Zyxin (see above).Discussion
Zyxin binds to Gli1 and thereby interferes with its transcription
function
In this study, we present several independent lines of evidence
that cytoskeletal protein Zyxin can directly interact with transcrip-
tion factor Gli1. This interaction is largely mediated by LIM2
domain of Zyxin and the ﬁrst two zinc-ﬁngers of Gli1. The latter
region does not contact with DNA when Gli1 binds to its genomic
target site (Pavletich and Pabo, 1993) and represents the most
diverged part of its zinc-ﬁnger region. This fact rationally explains
why Zyxin in our experiments did not bind to close homologs of
Gli1–Gli2 and Gli3, whose genes are intensively expressed in
dorsal regions of the neural tube. Indeed, there is only 83% and
85% of identity between 1 and 2 zinc ﬁngers of Gli1 and Gli2 and
Gli3 respectively, while their 3–5 zinc-ﬁngers demonstrate almost
complete identity: 99%.
The ability of zinc-ﬁnger domain of Gli1 to interact with zinc-
ﬁnger domains of the same C2H2-Kruppel type was demonstrated
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evidence that 1 and 2 zinc-ﬁngers of Gli1 can also participate in
the interaction of another type: with the double-zinc ﬁnger motif
of LIM2-domain of cytoskeletal protein Zyxin.
As we have shown by EMSA, Zyxin suppresses Gli1 binding to
its DNA target. This result is well consistent with the functional
data obtained by using Luc-reporter system, which demonstrated
that Zyxin was able to suppress the transcriptional activity of Gli1
regardless of the activator (VP16) or the repressor (EnR) type of
transcriptional regulator fused to Zyxin. These observations indi-
cate that the most probable mechanism, by which Zyxin inhibits
the transcription function of Gli1, is the prevention of its interac-
tion with genetic targets.
By now, the interactions of Gli1 and some other members of
Shh signaling cascade were reported for the cytoskeletal proteins
associated with microtubules (see for review (Eggenschwiler and
Anderson, 2007; Ingham and McMahon, 2001). Our ﬁnding
indicating potential interaction of Gli1 through Zyxin with the
actin cytoskeleton extends the list of mechanisms responsible for
the regulation of the Shh cascade functioning.
Zyxin effect on Shh signaling might help to ﬁne tune early patterning
of the neural rudiment
The most convincing evidence of the inhibitory inﬂuence of
Zyxin upon Shh signaling through mediation of Gli1 is the
activating effect of antiZyxin Mo on the expression of Gli-Luc
reporter. Indeed, the presence within a reporter of cis-regulatory
elements speciﬁc for Gli binding ensures that only activity of the
endogenous Gli1 and/or Gli2 could be a direct cause of this effect.
However, since inhibition of Gli1, but not Gli2, prevented increase
of the reporter activity in conditions of the inhibited endogenous
Zyxin, one may conclude that just Gli1, but not Gli2, was actually
responsible for the observed up-regulation of the reporter. Impor-
tantly, these data are supported by results of other experiments,
including binding assay, expression analysis of Shh genetic targets
in embryos with up- and down-regulated Zyxin, as well as of
experiments that demonstrate ability of Zyxin to inhibit the
transcription function of Gli1, but not of Gli2 or Gli3, by preventing
its interaction with Gli-binding elements in the reporter promoter.
As we revealed, blocking of the endogenous Zyxin mRNA
translation by Mo led, at least in the midneurula stage embryos,
to inhibition of expression of the dorsal speciﬁc Shh target genes,
Dbx1, Olig4 and Pax6, which are normally down-regulated by high
Shh activity. Assuming the inhibitory effect of Zyxin upon Gli1
functioning, one may suppose that such an effect could result from
increased activity of Gli1. Indeed, we observed reduction of the
expression zones of Pax6 and Dbx1 in the neural tubes of embryos
with overexpressed Gli1. Meanwhile, since Gli1 operates as an
obligate transcriptional activator, it could not inhibit Pax6 and
Dbx1 directly. Rather, Gli1 activated the expression of some
intermediate transcriptional repressors of Pax6 and Dbx1. The role
of such a repressor could be played for example, by a transcription
factor Nkx2.2, which is up-regulated by Gli1 in the lateral ﬂoor
plate and causes inhibitory effects upon the expression of Pax6
(Balaskas et al., 2012; Peyrot et al., 2011). However, the expression
of Nkx2.2 could not be analyzed at the midneurula stage since it
starts at the end of neurulation, when the neural plates of embryos
injected by antiZyxin Mo begin to disintegrate (Movie S1). Thus,
other inhibitors of Pax6 and Dbx1, whose genes were activated in
these embryos, remain to be identiﬁed.
By contrast to the dorsally expressed markers, the expression of
the ventrally speciﬁc ones, which presumably should be up-
regulated by an increased Gli1 activity, was much poorly affected
in embryos with down-regulated Zyxin. At the same time, princi-
pal sensitivity of the ventral markers to the inhibitory effect ofZyxin on Shh signaling was demonstrated in our gain-of-function
experiments, in which high concentration of exogenous Zyxin
elicited slight down-regulation of Nkx2.2 and FoxA2.
It is reasonable to explain this apparent discrepancy by rather
moderate effect that Zyxin exerts on Shh signaling. Indeed, a decrease
of the endogenous Zyxin concentration could be sensitive only for
those genes, which are regulated, like Dbx1, by low concentrations of
Shh/Gli1, distantly from the ﬂoor plate (Fig. 3A and B in the present
paper and Briscoe et al. (2001)). In contrast, in the vicinity of the ﬂoor
plate, in regions located in the ventral part of the neural tube, where
the curve of Shh/Gli1 gradient sharply increases (Roelink et al., 1995;
Saha and Schaffer, 2006), such comparatively narrow variations of Shh
signaling, generated by a decrease of endogenous Zyxin, could not be
sensed by genes, whose expression is regulated normally by high
concentrations of Shh. Nevertheless, the principal sensitivity of the
ventral marker genes to the inhibitory effect of Zyxin on Shh signaling
was demonstrated in our gain-of-function experiments, in which high
concentration of exogenous Zyxin appeared to be able to elicit down-
regulation of Nkx2.2 and FoxA2.
One might also explain the difference in sensitivity to Zyxin
depletion between ventral and dorsal markers by suggestion that
Zyxin in the medial part of the neural plate cannot, for some
reasons, effectively bind Gli1. For example, Zyxin in these cells
might be tightly associated with the actin cytoskeleton, which does
not allow Zyxin to effectively sequester Gli1. In this case, a depletion
of Zyxin will cause in this medial cells only minor effect on the
expression of Gli1 targets, i.e. the effect, which we observed in
embryos with down-regulated Zyxin. On the contrary, in lateral
neural plate, Zyxin might be less co-opted into the cytoskeleton,
thereby being allowed to effectively interact with Gli1. In this case,
removal of Zyxin should result in an increase of the Gli1 activity
primarily in these peripheral regions, which is consistent with the
inhibition of dorsally expressed markers in embryos injected with
antiZyxin Mo. In support of this idea, we observed that Zyxin was
more associated with cell–cell contacts in cells of the medial part of
neural plate of transgenic embryos ubiquitously expressing Zyxin-
EGFP under the control of CMV promoter. However, further experi-
ments are necessary to test this hypothesis more thoroughly.
Finally, low effect of Zyxin depletion upon genes normally
expressed in the ﬂoor plate cells could be the result of a principal
low sensitivity of these genes to Shh signaling. Indeed, as it has
been shown, Shh signaling plays, at least in Xenopus, a minor role
in ﬂoor plate speciﬁcation (Peyrot et al., 2011).
It was reported recently that Zyxin recruitment from the cytoplasm
to the protein complex regulating actin ﬁlaments assembly in cell
contacts can be facilitated by the mechanical stresses generated as a
result of cell contractions or applied to the cell externally (Hirata et al.,
2008; Wolfenson et al., 2011). Accordingly, one may suppose that the
amount of free Zyxin available for its interaction with Gli1 might be
inversely dependent on Zyxin amount recruited into cell contacts,
which in turn is dependent on speciﬁc morphogenetic status of a
given cell. By this way, a feedback loop mediated by Zyxin might be
realized between Shh signaling and morphogenetic movements that
form the neural tube. Discovery and investigation of such feedback
loops will be important in the view of newly emerging ﬁeld of
research, which studies mechanical control, by the morphogenetic
movements, of gene expression based on biochemical mechanotrans-
duction processes (Belintsev et al., 1987; Beloussov et al., 2006;
Fernandez-Sanchez et al., 2010).Acnowlegements
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